| http://www.w3.org/ns/prov#value | - announced that it has received regulatory approval under the Investment Canada Act.05 November 2013Endo Health Solutions agreed to buy Canadian drug company Paladin Labs for about $1.6 billion to expand in that country and emerging markets.The purchase, mostly through stock, values each Paladin Labs share at C$77.The deal gives Endo access to the Canadian market.
|
